0.25Open0.20Pre Close11 Volume233 Open Interest7.50Strike Price200.00Turnover74.27%IV10.39%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier10DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.2957Delta0.4037Gamma46.20Leverage Ratio-0.0152Theta0.0005Rho13.66Eff Leverage0.0040Vega
Allot Stock Discussion
Allot Announces its New Service Gateway Tera III for Top Tier Telecom Operators
Allot (NASDAQ: ALLT) has unveiled its new Service Gateway Tera IIImultiservice platform, boasting the highest capacity in the telecommunications market at 2.8 Tbps. The platform delivers scalable carrier-grade performance for network intelligence, traffic management, and cybersecurity protection services in a unified solution. The SG-Tera III features up to 26x 400 Gbps ports or 104x 100 Gbps por...
📊⚡️📊
Positive
First non-GAAP operating profit ($1.1M) in three years
SECaaS revenues grew 69% YoY to $4.7M
Revenue increased 5% sequentially and 3% YoY to $23.2M
Non-GAAP gross margin improved to 71.7%
Generated positive operating cash flow of $1.9M
Net cash increased by $2.0M vs previous quarter
Negative
GAAP operating loss of $0.2M
GAAP net loss of $0.2M ($0.01 per share)
$Allot (ALLT.US)$ buy in 7.82 sell 12.25 after 8.23 the gaps are 9.76, 10.40, 11.34, 11.84 12.08.
$Synchronoss Technologies (SNCR.US)$ Buy in 1.59 sell 2.23.
$Puma Biotechnology (PBYI.US)$ buy in 2.72 sell 6.48.
$Avalo Therapeutics (AVTX.US)$ buy in .64. sell 1.76. Institutional investor has continued buying but the price may not have found bottom yet.
No comment yet